Abstract
Arterial stiffness, central haemodynamics and Non-Alcoholic Fatty Liver Disease (NAFLD) have been associated with increased risk for Cardiovascular (CV) morbidity and mortality. Antihypertensive, antidiabetic and hypolipidaemic drugs may affect these predictors of CV risk. Such associations should be taken into consideration when treating high-risk patients.
Keywords: Arterial stiffness, central haemodynamics, non-alcoholic fatty liver disease, cardiovascular risk, antihypertensive, hypolipidaemic drugs, antidiabetic drugs.
Current Vascular Pharmacology
Title:Editorial: Arterial Stiffness, Central Haemodynamics and Non-Alcoholic Fatty Liver Disease: Links with Cardiovascular Risk and Effects of Drug Treatment
Volume: 16 Issue: 4
Author(s): Niki Katsiki, Konstantinos Imprialos and Charalambos Vlachopoulos*
Affiliation:
- First Department of Cardiology, National and Kapodistrian University of Athens, Hippokration Hospital, Athens,Greece
Keywords: Arterial stiffness, central haemodynamics, non-alcoholic fatty liver disease, cardiovascular risk, antihypertensive, hypolipidaemic drugs, antidiabetic drugs.
Abstract: Arterial stiffness, central haemodynamics and Non-Alcoholic Fatty Liver Disease (NAFLD) have been associated with increased risk for Cardiovascular (CV) morbidity and mortality. Antihypertensive, antidiabetic and hypolipidaemic drugs may affect these predictors of CV risk. Such associations should be taken into consideration when treating high-risk patients.
Export Options
About this article
Cite this article as:
Katsiki Niki, Imprialos Konstantinos and Vlachopoulos Charalambos *, Editorial: Arterial Stiffness, Central Haemodynamics and Non-Alcoholic Fatty Liver Disease: Links with Cardiovascular Risk and Effects of Drug Treatment, Current Vascular Pharmacology 2018; 16 (4) . https://dx.doi.org/10.2174/1570161116666171205105402
DOI https://dx.doi.org/10.2174/1570161116666171205105402 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
Ischemic Cardiovascular Diseases: Mechanisms, Diagnosis and Therapy
Ischemic cardiovascular disease includes myocardial infarction, coronary atherosclerotic heart disease, angina pectoris, etc., constitute the leading cause of patient mortality by preventing tissues from getting sufficient oxygen and nutrients. Ischemic heart disease, as a clinical condition, is characterized by myocardial ischemia, causing an imbalance between myocardial blood supply and demand, ...read more
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Protective Effects of Natural Products on Blood-Brain Barrier Breakdown
Current Medicinal Chemistry Green Tea Polyphenols as an Anti-Oxidant and Anti-Inflammatory Agent for Cardiovascular Protection
Cardiovascular & Hematological Disorders-Drug Targets Recent Progress in Cerebrovascular Gene Therapy
Current Neurovascular Research Ambulatory Blood Pressure Monitoring in Prehypertensive Subjects
Cardiovascular & Hematological Disorders-Drug Targets Milk Fat Globule Epidermal Growth Factor VIII Signaling in Arterial Wall Remodeling
Current Vascular Pharmacology Comparison of the Acute Hematopoietic Capacities of Erythropoietin and U-74389G Concerning Hematocrit Levels
Cardiovascular & Hematological Disorders-Drug Targets Processing of Amyloid Precursor Protein as a Biochemical Link Between Atherosclerosis and Alzheimers Disease
Cardiovascular & Hematological Disorders-Drug Targets Whole-Cell Biosensors: Research and Patents
Recent Patents on Biomedical Engineering (Discontinued) Beta-Blockers use for Hypertension in the Elderly
Cardiovascular & Hematological Agents in Medicinal Chemistry Consequences of Iron Accumulation in Microglia and its Implications in Neuropathological Conditions
CNS & Neurological Disorders - Drug Targets The Effects of Medications Used for the Management of Dyslipidemia on Postprandial Lipemia
Current Medicinal Chemistry Current Medical and Surgical Stroke Prevention Therapies for Patients with Carotid Artery Stenosis
Current Neurovascular Research Ultrasonographic Assessment of Cirrhosis and Portal Hypertension
Current Medical Imaging Hematoma Expansion Following Intracerebral Hemorrhage: Mechanisms Targeting the Coagulation Cascade and Platelet Activation
Current Drug Targets Cardiovascular Diseases and the Nitric Oxide Pathway
Current Vascular Pharmacology Point of NO Return for Nitrergic Nerves in Diabetes: A New Insight into Diabetic Complications
Current Pharmaceutical Design Patterns of Self-Medication with Medicinal Plants and Related Adverse Events - A South American Survey
Current Drug Safety Impact of Chronic Kidney Disease on Risk for Vascular Events
Current Vascular Pharmacology MicroRNA Targeting as a Therapeutic Strategy Against Glioma
Current Molecular Medicine 1,8-Naphthyridine Derivatives: A Privileged Scaffold for Versatile Biological Activities
Mini-Reviews in Medicinal Chemistry